Vaccine Supply

The US government has extended its global vaccine supply quota to 80 million as President Joe Biden on May 17 announced an additional 20 million doses. Notably, 60 million AstraZeneca vaccines doses were approved earlier. The entirety of the doses will be supplied within next six weeks and it will include Pfizer-BioNTech, Moderna and Johnson & Johnson's vaccines as well. Currently, the vaccine doses are awaiting safety clearances.